Intensity Therapeutics, Inc. (INTS)
0.3756
0.00 (0.00%)
USD |
NASDAQ |
Dec 31, 09:30
Intensity Therapeutics EPS Diluted (Quarterly): -0.062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Harvard Bioscience, Inc. | -0.0276 |
| Moleculin Biotech, Inc. | -17.02 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.671M |
| Total Expenses (Quarterly) | 2.671M |
| Enterprise Value | 15.61M |
| Earnings Yield | -169.0% |
| Normalized Earnings Yield | -168.98 |